Get started
Author

Andrea Tomirotti

Observed names: Andrea M Tomirotti, Andrea M. Tomirotti, Andrea M. Tomirotti (14942785), Andrea Massimiliano Tomirotti, Tomirotti, Andrea Massimiliano
ORCID: 0000-0001-5295-4162
Observed ORCID: 0000-0001-5295-4162
OpenAlex ID: A5002278917
Osteopontin Shapes Immunosuppression in the Metastatic Niche
2014 · Sabina Sangaletti, Claudio Tripodo, et al. · Cancer Research · 161
PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity
2020 · Maciej Szydłowski, Sonia Dębek, et al. · American Journal Of Pathology · 29
PDF
Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAs
2019 · Claudia Chiodoni, Valeria Cancila, et al. · Cancer Research · 20
PDF
PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium
2020 · Filip Garbicz, Anna Szumera-Ciećkiewicz, et al. · Blood · 3
Data from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies
2023 · Maciej Szydłowski, Filip Garbicz, et al.
Supplementary Materials from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies
2023 · Maciej Szydłowski, Filip Garbicz, et al.
Supplementary Table from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies
2023 · Maciej Szydłowski, Filip Garbicz, et al.
PDF
Supplementary Table from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies
2023 · Maciej Szydłowski, Filip Garbicz, et al.
Data from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies
2023 · Maciej Szydłowski, Filip Garbicz, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
PDF
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
PDF
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
PDF
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
PDF
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
PDF
Data Supplement from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
PDF
Data from Osteopontin Shapes Immunosuppression in the Metastatic Niche
2023 · Sabina Sangaletti, Claudio Tripodo, et al.
Abstract PS18-26: Men1611 promotes immune activating myeloid cell polarization
2021 · Stefania Capano, Alessandro Paoli, et al. · Cancer Research
Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies
2020 · Maciej Szydlowski, Filip Garbicz, et al. · Blood
Works count: 35
Citation count: 213
H-index: 3
I10-index: 3
Year
Topic
Type